NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Seriously? The OTC is not registered under section 6 of the Securities Exchange Act. That means they are not a National Exchange.

This is the list, per the SEC

Everybody knows the OTC has far less disclosure rules by law.

As far as the reason for NWBO delisting, that is pure crap. They were subject to 2 delisting notices at the time the fled.

The NWBO 8K on the subject

As reported in the Company’s quarterly report on form 10-Q, on November 7, 2016 the Company received a letter from Nasdaq indicating that certain of the Company’s financing transactions did not comply with Nasdaq’s Listing Rule 5635(d). The Nasdaq Staff had determined to aggregate a series of transactions that were completed between May 15, 2016 and October 13, 2016 for purposes of assessing whether the 20% threshold for shareholder approval had been triggered for issuances priced below the applicable market price. These transactions included repricing of existing common stock purchase warrants and issuances of new common shares and common stock purchase warrants.

As also reported in the Company’s 10-Q, the Company and its representatives are in discussions with the Nasdaq Staff regarding available avenues for remediation, and the Company intends to submit its plan of remediation to Nasdaq on or before the November 18, 2016 deadline established by Nasdaq (The Nasdaq Staff shortened the 45 day period for submitting a plan, pursuant to their discretionary authority under Listing Rule 5101. The Staff based this determination on the Company’s recent shareholder approval violation, pending bid price grace period and concerns about the Company’s internal processes for review of transactions such as these). If Nasdaq does not accept the plan of remediation, Nasdaq may issue a notice of delisting. The Company would then have the right to request a hearing before an independent Nasdaq Listing Qualifications Panel (the “Panel”). A request for a hearing would stay any suspension or delisting action pending the hearing and the expiration of any additional extension period granted by the Panel. The Panel would have the discretion to grant the Company an extension period of up to 180 calendar days from the date of the delisting letter within which the Company would be required to demonstrate compliance with all applicable listing requirements. Notwithstanding the foregoing, there can be no assurance that the Company will be able to satisfy the applicable listing requirements and maintain its listing on The Nasdaq Stock Market.

The NASDAQ rules are that if one wants to sell a lot of shares, they must allow a shareholder vote on it. LP does not like that concept. all NWO ever had to do was allow a vote on the sales.